Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients
Mónica Macías(Clinica Universidad de Navarra), Álvaro González(Memorial Sloan Kettering Cancer Center), A. Ma Navarro(Clinica Universidad de Navarra), Daniel Ajona(Clinica Universidad de Navarra), Susana Chocarro(Clinica Universidad de Navarra), A. Garcia-Cortes(Clinica Universidad de Navarra), D. Rosell(Clinica Universidad de Navarra), J.E. Robles(Clinica Universidad de Navarra), Javier Ancizu‐Marckert(Clinica Universidad de Navarra), Alfonso Gúrpide(Clinica Universidad de Navarra), José Luis Perez‐Gracia(Clinica Universidad de Navarra), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Estíbaliz Alegre(Navarre Institute of Health Research), Oihane Bedialauneta(Universidad de Navarra), F. Díez‐Caballero(Clinica Universidad de Navarra), Beatriz Mateos(Clinica Universidad de Navarra), Juan I. Pascual(Clinica Universidad de Navarra), Maria Pilar Andueza(Clinica Universidad de Navarra), Bernardino Miñana(Clinica Universidad de Navarra), Marcos Torres(Clinica Universidad de Navarra)
Cited by 20
Related Papers
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
|British Journal of Cancer|2009|209
Granulocyte Colony-Stimulating Factor in the Treatment of High-Risk Febrile Neutropenia: a Multicenter Randomized Trial
|JNCI Journal of the National Cancer Institute|2001|179
Multitask learning improves prediction of cancer drug sensitivity
|Scientific Reports|2016|110